FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Medical Device Data Systems Guidance

FDA publishes a revised guidance on medical device data systems to conform with the 21st Century Cures Act.

latest-news-card-1
Federal Register

Animal Drug Application Actions Posted

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug applications and abbreviate...

latest-news-card-1
Federal Register

Meeting on Animal Generic Drug User Fees

Federal Register notice: FDA announces a 10/26 public meeting entitled Animal Generic Drug User Fee Act.

latest-news-card-1
Human Drugs

FDA in New AMP Heart Failure Program

FDA joins with the NIH and other organizations in a new Accelerating Medicines Partnership program on heart failure.

latest-news-card-1
Biologics

Sarepta Submits BLA for Duchenne Gene Therapy

Sarepta Therapeutics files a BLA seeking accelerated approval of SRP-9001 (delandistrogene moxeparvovec) to treat ambulant patients with Duchenne musc...

latest-news-card-1
Human Drugs

Dupixent Gains OK for Prurigo Nodularis

FDA approves Regeneron Pharmaceuticals Dupixent (dupilumab) for treating adult patients with prurigo nodularis. a chronic, inflammatory skin disease.

latest-news-card-1
Human Drugs

Comments on COA Guidance

Four stakeholders suggest ways FDA could improve a draft guidance on fit-for-use clinical outcome assessments.

latest-news-card-1
Animal Drugs

Generic Adspec Approved for Bovine Pneumonia

FDA approves Bimeda Animal Healths SpectoGard (spectinomycin sulfate), the first generic copy of Pharmacia Animal Healths Adspec.

latest-news-card-1
Human Drugs

Mfr. Deficiencies Hamper 1st Cycle ANDA Reviews

Writing in a medical journal, CDER researchers say manufacturing-related deficiencies contribute significantly to a low first-review-cycle approval ra...

latest-news-card-1
Federal Register

Final Guide on Revised Covid Test Policy

Federal Register notice: FDA makes available a final guidance entitled Policy for Coronavirus Disease 2019 Tests During the Public Health Emergency (...